<?xml version='1.0' encoding='UTF-8'?>
<uniprot>
<entry dataset="Swiss-Prot" created="1989-10-01" modified="2015-01-07" version="178">
<accession>P12268</accession>
<accession>Q6LEF3</accession>
<name>IMDH2_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="4">Inosine-5'-monophosphate dehydrogenase 2</fullName>
<shortName evidence="4">IMP dehydrogenase 2</shortName>
<shortName evidence="4">IMPD 2</shortName>
<shortName evidence="4">IMPDH 2</shortName>
<ecNumber evidence="4">1.1.1.205</ecNumber>
</recommendedName>
<alternativeName>
<fullName>IMPDH-II</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="4">IMPDH2</name>
<name type="synonym">IMPD2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="15769" last="15772">
<title>Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs.</title>
<authorList>
<person name="Collart F.R."/>
<person name="Huberman E."/>
</authorList>
<dbReference type="PubMed" id="2902093"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="5292" last="5295">
<title>Two distinct cDNAs for human IMP dehydrogenase.</title>
<authorList>
<person name="Natsumeda Y."/>
<person name="Ohno S."/>
<person name="Kawasaki H."/>
<person name="Konno Y."/>
<person name="Weber G."/>
<person name="Suzuki K."/>
</authorList>
<dbReference type="PubMed" id="1969416"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="205" first="537" last="544">
<title>Cloning and sequence of the human type II IMP dehydrogenase gene.</title>
<authorList>
<person name="Glesne D.A."/>
<person name="Huberman E."/>
</authorList>
<dbReference type="PubMed" id="7999076"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.2698"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="6808" last="6814">
<title>Characterization of the human inosine-5'-monophosphate dehydrogenase type II gene.</title>
<authorList>
<person name="Zimmermann A.G."/>
<person name="Spychala J."/>
<person name="Mitchell B.S."/>
</authorList>
<dbReference type="PubMed" id="7896827"/>
<dbReference type="DOI" id="10.1074/jbc.270.12.6808"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>B-cell</tissue>
<tissue>Colon</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1993" name="Genomics" volume="16" first="274" last="277">
<title>Chromosomal localization and structure of the human type II IMP dehydrogenase gene.</title>
<authorList>
<person name="Glesne D.A."/>
<person name="Collart F.R."/>
<person name="Varkony T."/>
<person name="Drabkin H."/>
<person name="Huberman E."/>
</authorList>
<dbReference type="PubMed" id="8098009"/>
<dbReference type="DOI" id="10.1006/geno.1993.1177"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 461-514</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="27286" last="27290">
<title>Characterization of human type I and type II IMP dehydrogenases.</title>
<authorList>
<person name="Carr S.F."/>
<person name="Papp E."/>
<person name="Wu J.C."/>
<person name="Natsumeda Y."/>
</authorList>
<dbReference type="PubMed" id="7903306"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-11</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Biochem. Pharmacol." volume="49" first="1323" last="1329">
<title>Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.</title>
<authorList>
<person name="Hager P.W."/>
<person name="Collart F.R."/>
<person name="Huberman E."/>
<person name="Mitchell B.S."/>
</authorList>
<dbReference type="PubMed" id="7763314"/>
<dbReference type="DOI" id="10.1016/0006-2952(95)00026-V"/>
</citation>
<scope>PROTEIN SEQUENCE OF N-TERMINUS</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Biochem. J." volume="379" first="243" last="251">
<title>Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo.</title>
<authorList>
<person name="McLean J.E."/>
<person name="Hamaguchi N."/>
<person name="Belenky P."/>
<person name="Mortimer S.E."/>
<person name="Stanton M."/>
<person name="Hedstrom L."/>
</authorList>
<dbReference type="PubMed" id="14766016"/>
<dbReference type="DOI" id="10.1042/BJ20031585"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEIC ACID-BINDING</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-400</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Pharmacogenet. Genomics" volume="17" first="283" last="290">
<title>A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.</title>
<authorList>
<person name="Wang J."/>
<person name="Zeevi A."/>
<person name="Webber S."/>
<person name="Girnita D.M."/>
<person name="Addonizio L."/>
<person name="Selby R."/>
<person name="Hutchinson I.V."/>
<person name="Burckart G.J."/>
</authorList>
<dbReference type="PubMed" id="17496727"/>
<dbReference type="DOI" id="10.1097/FPC.0b013e328012b8cf"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>VARIANT PHE-263</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-511</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122 AND SER-416</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="3531" last="3536">
<title>Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.</title>
<authorList>
<person name="Colby T.D."/>
<person name="Vanderveen K."/>
<person name="Strickler M.D."/>
<person name="Markham G.D."/>
<person name="Goldstein B.M."/>
</authorList>
<dbReference type="PubMed" id="10097070"/>
<dbReference type="DOI" id="10.1073/pnas.96.7.3531"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS)</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="19">
<citation type="submission" date="2002-12" db="PDB data bank">
<title>Crystal structure of human inosine monophosphate dehydrogenase type II complexed with the MPA/NAD analog C2-MAD.</title>
<authorList>
<person name="Risal D."/>
<person name="Strickler M.D."/>
<person name="Goldstein B.M."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) IN COMPLEX WITH INHIBITOR AND POTASSIUM</scope>
</reference>
<reference key="20">
<citation type="submission" date="2002-12" db="PDB data bank">
<title>The conformation of NAD bound to human inosine monophosphate Dehydrogenase Type II.</title>
<authorList>
<person name="Risal D."/>
<person name="Strickler M.D."/>
<person name="Goldstein B.M."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) IN COMPLEX WITH NAD(+)</scope>
</reference>
<comment type="function">
<text>Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors.</text>
</comment>
<comment type="catalytic activity">
<text evidence="4">Inosine 5'-phosphate + NAD(+) + H(2)O = xanthosine 5'-phosphate + NADH.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>K(+)</name>
<dbReference type="ChEBI" id="CHEBI:29103"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="4 13">Mycophenolic acid (MPA) is a non-competitive inhibitor that prevents formation of the closed enzyme conformation by binding to the same site as the amobile flap. In contrast, mizoribine monophosphate (MZP) is a competitive inhibitor that induces the closed conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of bacterial IMPDH. Subject to product inhibition by XMP and NADH. Also inhibited by ADP.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="12 13">9.3 uM for Inosine 5'-phosphate</KM>
<KM evidence="12 13">32 uM for NAD(+)</KM>
</kinetics>
</comment>
<comment type="pathway" evidence="4">
<text>Purine metabolism; XMP biosynthesis via de novo pathway; XMP from IMP: step 1/1.</text>
</comment>
<comment type="subunit">
<text evidence="4 13 14 15">Homotetramer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4 6">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4 6">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>IMP type I is the main species in normal leukocytes and type II predominates over type I in the tumor.</text>
</comment>
<comment type="induction">
<text>Selectively up-regulated in neoplastic and replicating cells.</text>
</comment>
<comment type="PTM">
<text>The N-terminus is blocked.</text>
</comment>
<comment type="polymorphism">
<text>Genetic variants in the IMPDH2 gene may account for the large inter-individual variability in enzyme activity, immunosuppressive efficacy and side effects in transplant recipients receiving mycophenolic acid.</text>
</comment>
<comment type="miscellaneous">
<text>Because IMPDH activity is tightly linked with cell proliferation, it has been recognized as a target for cancer and viral chemotherapy and as a target for immunosuppressive drugs. The activities of the antitumor drug tiazofurin, the antiviral drug ribavirin, and the immunosuppressive drugs mizoribine and mycophenolic acid (MPA) are attributed to the inhibition of IMPDH. In addition, bacterial and parasitic IMPDH's differ significantly from mammalian enzymes, which makes it a suitable target for anti-infective drugs.</text>
</comment>
<comment type="similarity">
<text evidence="4">Belongs to the IMPDH/GMPR family.</text>
</comment>
<comment type="similarity">
<text evidence="4">Contains 2 CBS domains.</text>
</comment>
<dbReference type="EC" id="1.1.1.205" evidence="4"/>
<dbReference type="EMBL" id="J04208">
<property type="protein sequence ID" value="AAA36112.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L33842">
<property type="protein sequence ID" value="AAA67054.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L39210">
<property type="protein sequence ID" value="AAB70699.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC006124">
<property type="protein sequence ID" value="AAH06124.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012840">
<property type="protein sequence ID" value="AAH12840.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015567">
<property type="protein sequence ID" value="AAH15567.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L08114">
<property type="protein sequence ID" value="AAA36113.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2786.1"/>
<dbReference type="PIR" id="I52303">
<property type="entry name" value="A31997"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000875.2">
<property type="nucleotide sequence ID" value="NM_000884.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.654400"/>
<dbReference type="PDB" id="1B3O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=1-514"/>
</dbReference>
<dbReference type="PDB" id="1NF7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B=1-514"/>
</dbReference>
<dbReference type="PDB" id="1NFB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=1-514"/>
</dbReference>
<dbReference type="PDBsum" id="1B3O"/>
<dbReference type="PDBsum" id="1NF7"/>
<dbReference type="PDBsum" id="1NFB"/>
<dbReference type="ProteinModelPortal" id="P12268"/>
<dbReference type="SMR" id="P12268">
<property type="residue range" value="10-514"/>
</dbReference>
<dbReference type="BioGrid" id="109828">
<property type="interactions" value="41"/>
</dbReference>
<dbReference type="IntAct" id="P12268">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="MINT" id="MINT-2860057"/>
<dbReference type="STRING" id="9606.ENSP00000321584"/>
<dbReference type="BindingDB" id="P12268"/>
<dbReference type="ChEMBL" id="CHEMBL2002"/>
<dbReference type="DrugBank" id="DB01033">
<property type="generic name" value="Mercaptopurine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00688">
<property type="generic name" value="Mycophenolate mofetil"/>
</dbReference>
<dbReference type="DrugBank" id="DB01024">
<property type="generic name" value="Mycophenolic acid"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2625"/>
<dbReference type="PhosphoSite" id="P12268"/>
<dbReference type="DMDM" id="124419"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00291510"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P12268"/>
<dbReference type="UCD-2DPAGE" id="P12268"/>
<dbReference type="MaxQB" id="P12268"/>
<dbReference type="PaxDb" id="P12268"/>
<dbReference type="PeptideAtlas" id="P12268"/>
<dbReference type="PRIDE" id="P12268"/>
<dbReference type="DNASU" id="3615"/>
<dbReference type="Ensembl" id="ENST00000326739">
<property type="protein sequence ID" value="ENSP00000321584"/>
<property type="gene ID" value="ENSG00000178035"/>
</dbReference>
<dbReference type="GeneID" id="3615"/>
<dbReference type="KEGG" id="hsa:3615"/>
<dbReference type="UCSC" id="uc003cvt.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3615"/>
<dbReference type="GeneCards" id="GC03M049061"/>
<dbReference type="HGNC" id="HGNC:6053">
<property type="gene designation" value="IMPDH2"/>
</dbReference>
<dbReference type="HPA" id="CAB020717"/>
<dbReference type="HPA" id="HPA001400"/>
<dbReference type="MIM" id="146691">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P12268"/>
<dbReference type="PharmGKB" id="PA29863"/>
<dbReference type="eggNOG" id="COG0517"/>
<dbReference type="GeneTree" id="ENSGT00530000062923"/>
<dbReference type="HOGENOM" id="HOG000165752"/>
<dbReference type="HOVERGEN" id="HBG052122"/>
<dbReference type="KO" id="K00088"/>
<dbReference type="OMA" id="RVRDVFQ"/>
<dbReference type="PhylomeDB" id="P12268"/>
<dbReference type="TreeFam" id="TF300378"/>
<dbReference type="BioCyc" id="MetaCyc:HS11242-MONOMER"/>
<dbReference type="Reactome" id="REACT_1776">
<property type="pathway name" value="Purine ribonucleoside monophosphate biosynthesis"/>
</dbReference>
<dbReference type="SABIO-RK" id="P12268"/>
<dbReference type="UniPathway" id="UPA00601">
<property type="reaction ID" value="UER00295"/>
</dbReference>
<dbReference type="ChiTaRS" id="IMPDH2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P12268"/>
<dbReference type="GeneWiki" id="IMPDH2"/>
<dbReference type="GenomeRNAi" id="3615"/>
<dbReference type="NextBio" id="14143"/>
<dbReference type="PRO" id="PR:P12268"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="P12268"/>
<dbReference type="CleanEx" id="HS_IMPDH2"/>
<dbReference type="ExpressionAtlas" id="P12268">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevestigator" id="P12268"/>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular vesicular exosome"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005778">
<property type="term" value="C:peroxisomal membrane"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030554">
<property type="term" value="F:adenyl nucleotide binding"/>
<property type="evidence" value="IEA:InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003938">
<property type="term" value="F:IMP dehydrogenase activity"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="IEA:UniProtKB-HAMAP"/>
</dbReference>
<dbReference type="GO" id="GO:0000166">
<property type="term" value="F:nucleotide binding"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071353">
<property type="term" value="P:cellular response to interleukin-4"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006177">
<property type="term" value="P:GMP biosynthetic process"/>
<property type="evidence" value="IEA:UniProtKB-HAMAP"/>
</dbReference>
<dbReference type="GO" id="GO:0046651">
<property type="term" value="P:lymphocyte proliferation"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0055086">
<property type="term" value="P:nucleobase-containing small molecule metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051289">
<property type="term" value="P:protein homotetramerization"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006144">
<property type="term" value="P:purine nucleobase metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009168">
<property type="term" value="P:purine ribonucleoside monophosphate biosynthetic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060041">
<property type="term" value="P:retina development in camera-type eye"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044281">
<property type="term" value="P:small molecule metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="3.20.20.70">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_01964">
<property type="entry name" value="IMPDH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR013785">
<property type="entry name" value="Aldolase_TIM"/>
</dbReference>
<dbReference type="InterPro" id="IPR000644">
<property type="entry name" value="CBS_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR005990">
<property type="entry name" value="IMP_DH"/>
</dbReference>
<dbReference type="InterPro" id="IPR015875">
<property type="entry name" value="IMP_DH/GMP_Rdtase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001093">
<property type="entry name" value="IMP_DH_GMPRt"/>
</dbReference>
<dbReference type="Pfam" id="PF00571">
<property type="entry name" value="CBS"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00478">
<property type="entry name" value="IMPDH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000130">
<property type="entry name" value="IMPDH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00116">
<property type="entry name" value="CBS"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR01302">
<property type="entry name" value="IMP_dehydrog"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51371">
<property type="entry name" value="CBS"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00487">
<property type="entry name" value="IMP_DH_GMP_RED"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0129">CBS domain</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0332">GMP biosynthesis</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0630">Potassium</keyword>
<keyword id="KW-0658">Purine biosynthesis</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<feature type="initiator methionine" description="Removed" evidence="4 13">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Inosine-5'-monophosphate dehydrogenase 2" id="PRO_0000093673">
<location>
<begin position="2"/>
<end position="514"/>
</location>
</feature>
<feature type="domain" description="CBS 1" evidence="4">
<location>
<begin position="114"/>
<end position="173"/>
</location>
</feature>
<feature type="domain" description="CBS 2" evidence="4">
<location>
<begin position="179"/>
<end position="237"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD">
<location>
<begin position="274"/>
<end position="276"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="4">
<location>
<begin position="324"/>
<end position="326"/>
</location>
</feature>
<feature type="region of interest" description="IMP binding">
<location>
<begin position="364"/>
<end position="366"/>
</location>
</feature>
<feature type="region of interest" description="IMP binding">
<location>
<begin position="387"/>
<end position="388"/>
</location>
</feature>
<feature type="region of interest" description="IMP binding" evidence="4">
<location>
<begin position="411"/>
<end position="415"/>
</location>
</feature>
<feature type="active site" description="Thioimidate intermediate" evidence="4 5">
<location>
<position position="331"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium; via carbonyl oxygen" evidence="4 14">
<location>
<position position="326"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium; via carbonyl oxygen" evidence="4 14">
<location>
<position position="328"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium; via carbonyl oxygen" evidence="4 14">
<location>
<position position="331"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium; via carbonyl oxygen; shared with tetrameric partner" evidence="4">
<location>
<position position="500"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium; via carbonyl oxygen; shared with tetrameric partner" evidence="4">
<location>
<position position="501"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium; via carbonyl oxygen; shared with tetrameric partner" evidence="4">
<location>
<position position="502"/>
</location>
</feature>
<feature type="binding site" description="IMP" evidence="4">
<location>
<position position="329"/>
</location>
</feature>
<feature type="binding site" description="IMP" evidence="4">
<location>
<position position="441"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 11">
<location>
<position position="122"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="400"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="416"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="10">
<location>
<position position="511"/>
</location>
</feature>
<feature type="sequence variant" description="Found in transplant patients; functional polymorphism that results in 10-fold decrease of enzymatic activity; dbSNP:rs121434586." id="VAR_070542" evidence="8">
<original>L</original>
<variation>F</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36112." ref="1" evidence="16">
<original>AG</original>
<variation>RS</variation>
<location>
<begin position="190"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="17"/>
<end position="19"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="20"/>
<end position="24"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="25"/>
<end position="27"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="32"/>
<end position="34"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="46"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="53"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="60"/>
<end position="67"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="71"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="77"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="97"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="112"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="147"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="161"/>
<end position="164"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="194"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="214"/>
<end position="216"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="220"/>
<end position="222"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="247"/>
<end position="250"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="256"/>
<end position="265"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="270"/>
<end position="273"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="281"/>
<end position="293"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="295"/>
<end position="304"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="307"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="319"/>
<end position="323"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="328"/>
<end position="331"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="333"/>
<end position="336"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="343"/>
<end position="354"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="355"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="361"/>
<end position="365"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="370"/>
<end position="378"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="382"/>
<end position="387"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="388"/>
<end position="390"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="396"/>
<end position="398"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="404"/>
<end position="406"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="409"/>
<end position="412"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="444"/>
<end position="447"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="453"/>
<end position="471"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="476"/>
<end position="484"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="490"/>
<end position="492"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="495"/>
<end position="501"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1B3O"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1NF7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1NFB"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="HAMAP-Rule" id="MF_03156"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10097070"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14766016"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17496727"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7763314"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7903306"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source ref="19"/>
</evidence>
<evidence key="15" type="ECO:0000269">
<source ref="20"/>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<sequence length="514" mass="55805" checksum="876BEA0EC1DDBEE9" modified="1991-05-01" version="2">
MADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKIT
LKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVV
LSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMT
KREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDA
KKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVI
GGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVP
VIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAM
DKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVR
AMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>